Semax vs Selank
Semax and Selank are both Russian-developed nootropic peptides administered intranasally, but they target different aspects of brain function. Semax is primarily discussed for cognitive enhancement and neuroprotection, while Selank is focused on anxiety reduction and stress resilience.
Semax
A synthetic peptide analog of ACTH(4-10) developed in Russia, studied for cognitive enhancement and neuroprotection.
Selank
A synthetic peptide analog of tuftsin with anxiolytic and nootropic properties, developed in Russia.
| Category | Semax | Selank |
|---|---|---|
| Primary Focus | Cognition, focus, neuroprotection | Anxiety reduction, stress resilience, calm |
| Key Mechanism | BDNF upregulation, dopamine/serotonin modulation | GABA enhancement, serotonin metabolism modulation |
| Regulatory Status | Approved in Russia for cognitive/neurological conditions | Approved in Russia for generalized anxiety |
| Evidence Base | Moderate (primarily Russian clinical literature) | Moderate (primarily Russian clinical literature) |
| Typical User Profile | Seeking focus, mental clarity, cognitive support | Seeking calm, anxiety relief, stress management |
| Administration | Intranasal spray | Intranasal spray |
Summary
The choice between Semax and Selank often comes down to the primary goal. If the main concern is cognitive performance, focus, and neuroprotection, Semax is typically the compound discussed. If anxiety, stress, and emotional regulation are the primary concerns, Selank is more commonly considered. Some practitioners discuss using both together — Semax for cognitive drive and Selank for emotional balance — though this combination should be guided by a clinician. Both compounds have the caveat that most clinical data comes from Russian studies, and Western clinical trial data is limited.
These peptides are often used together. See our stack profiles for combination details.